BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15082872)

  • 21. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.
    Helton DR; Tizzano JP; Monn JA; Schoepp DD; Kallman MJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):651-60. PubMed ID: 9454811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models.
    Kłodzińska A; Chojnacka-Wójcik E; Pałucha A; Brański P; Popik P; Pilc A
    Neuropharmacology; 1999 Dec; 38(12):1831-9. PubMed ID: 10608278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacology of uxepam].
    Zakusov VV; Voronina TA; Garibova TL; Pálosi E; Sporni L
    Farmakol Toksikol; 1983; 46(6):5-9. PubMed ID: 6140185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some behavioral effects of microinjections of noradrenaline and serotonin into the hippocampus of the rat.
    Płaźnik A; Danysz W; Kostowski W
    Physiol Behav; 1983 Nov; 31(5):625-31. PubMed ID: 6320239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiogenic-like action of galanin after intra-amygdala administration in the rat.
    Möller C; Sommer W; Thorsell A; Heilig M
    Neuropsychopharmacology; 1999 Oct; 21(4):507-12. PubMed ID: 10481834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychotropic effects of glutamic acid diethyl ester in mice].
    Kovalev GV; Sazhin VA; Ianitskaia AV
    Biull Eksp Biol Med; 1989 Sep; 108(9):302-4. PubMed ID: 2611385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of anxiolytics (5)--Vogel-type conflict task in mice].
    Umezu T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):305-14. PubMed ID: 7584725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The class I metabotropic glutamate receptor antagonist, AIDA, improves short-term and impairs long-term memory in a spatial task for rats.
    Christoffersen GR; Christensen LH; Hammer P; Vang M
    Neuropharmacology; 1999 Jun; 38(6):817-23. PubMed ID: 10465685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Behavioral models of anxiety in animals].
    Thiebot MH
    Encephale; 1983; 9(4 Suppl 2):167B-176B. PubMed ID: 6144511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some behavioral effects of chlorodesmethyldiazepam and lorazepam.
    Kostowski W; Płaźnik A; Puciłowski O; Trzaskowska E; Lipińska T
    Pol J Pharmacol Pharm; 1981; 33(6):597-602. PubMed ID: 6127668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential anxiolytic-like activity of some amino acid derivatives.
    Paruszewski R; Kłodzińska A; Chojnacka-Wójcik E
    Pharmazie; 1998 Feb; 53(2):124-5. PubMed ID: 9540109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats].
    Talalaenko AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class I mGlu receptor antagonist 1-aminoindan-1,5-dicarboxylic acid blocks contextual but not cue conditioning in rats.
    Nielsen KS; Macphail EM; Riedel G
    Eur J Pharmacol; 1997 May; 326(2-3):105-8. PubMed ID: 9196260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of tranquilizers on the interaction processes of positive and negative reinforcement systems].
    Kiseleva OV
    Farmakol Toksikol; 1979; 42(4):346-8. PubMed ID: 38993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of calcium channel blockers on anxiety evoked by amputation of the vibrissae in rats].
    Kozlovskiĭ VL; Mosin AE; Ivakina LV
    Eksp Klin Farmakol; 1997; 60(1):10-2. PubMed ID: 9162271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonflict effects of low doses of chloroquine.
    Egbe PC
    Arzneimittelforschung; 1990 Aug; 40(8):847-50. PubMed ID: 2242074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The nootropic and anxiolytic properties of different doses of piracetam].
    Voronina TA; Molodavkin GM; Borlikova GG; Ostrovskaia RU; Tushmalova NA; Naznamov GG
    Eksp Klin Farmakol; 2000; 63(2):9-11. PubMed ID: 10834086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anxiolytic drugs and inhibition].
    Zarifian E
    Encephale; 1978; 4(5 Suppl):547-51. PubMed ID: 38106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?
    Pellow S
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):557-65. PubMed ID: 2877126
    [No Abstract]   [Full Text] [Related]  

  • 40. The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats.
    Chojnacka-Wójcik E; Tatarczyńska E; Pilc A
    Eur J Pharmacol; 1997 Jan; 319(2-3):153-6. PubMed ID: 9042585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.